-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On January 5, 2023, on-site negotiations for the adjustment of the national medical insurance drug list officially began
.
The drugs negotiated this time involve hundreds of clinical drugs
such as tumors, rare diseases, and new coronavirus infection.
Since the establishment of the National Health Insurance Administration, the list of medical insurance drugs has been adjusted for four consecutive years, and a total of 507 new drugs and good drugs have been included and 391 drugs
with uncertain efficacy have been transferred.
The total number of drugs in the current version of the medical insurance catalogue has increased to 2,860, and the average price of drugs included in the medical insurance has been reduced by more than 50%, effectively reducing the burden
on patients.
.
The drugs negotiated this time involve hundreds of clinical drugs
such as tumors, rare diseases, and new coronavirus infection.
Since the establishment of the National Health Insurance Administration, the list of medical insurance drugs has been adjusted for four consecutive years, and a total of 507 new drugs and good drugs have been included and 391 drugs
with uncertain efficacy have been transferred.
The total number of drugs in the current version of the medical insurance catalogue has increased to 2,860, and the average price of drugs included in the medical insurance has been reduced by more than 50%, effectively reducing the burden
on patients.
